Covid: vaccine coming as an intranasal spray, pill or powder… More on the ongoing researches

Published by Laurent P. · Updated on 15 September 2021 at 11h19 · Published on 13 September 2021 at 10h50
As Covid vaccine campaigns go on across the world, searchers keep working on new ways to give the vaccine. Spray, pill, powder… Keep reading to find out more about the ongoing researches!

A Covid vaccine coming as a pill, a spray or even in powder… Here are the ongoing researchers by laboratories across the world, carried out by several scientific teams working on other ways to give the different vaccines already available on the market.

Three administration means being studied shared by the BBC, showing the ongoing studies were coming along nicely. They have a first example with the spray vaccine – or to be precise, the vaccine through inhalation – currently studied in Sweden, “half the size of a matchbox”. Designed by Iconovo and the ISR research start-up, it could come in as a powder likely using virus proteins (namely viral vector).

A technique also studied by Pfizer, enabling to keep the vaccine to temperatures up to 40°C (104°F). In France and across the world, the spray technology also triggers a lot of interest, so much that clinical trials have been launched.

Vaccin contre la Covid : un spray nasal en développement ?Vaccin contre la Covid : un spray nasal en développement ?Vaccin contre la Covid : un spray nasal en développement ?Vaccin contre la Covid : un spray nasal en développement ? Covid: take a stock on intranasal vaccines under development
Will the fight against Covid involve a nasal spray? Many searchers are working hard to develop a vaccine using this method, like searchers from the Tours university and Inrae who may be able to develop a vaccine using this technology within a few months. Here are all works conducted on the matter. [Read more]

Covid : le vaccin en spray nasal de l'Inrae et de l'Université de Tours bientôt commercialisé ?Covid : le vaccin en spray nasal de l'Inrae et de l'Université de Tours bientôt commercialisé ?Covid : le vaccin en spray nasal de l'Inrae et de l'Université de Tours bientôt commercialisé ?Covid : le vaccin en spray nasal de l'Inrae et de l'Université de Tours bientôt commercialisé ? Covid: intranasal vaccine by the Inrae and the Tours University soon to be commercialized?
Is a genuinely effective intranasal covid vaccine soon to be available? This is what searchers from the Inrae and the Tours University say as they registered a patent on Thursday September 9, 2021 as for a candidate vaccine that led to promising results on animals, according to scientists. This intranasal spray could be marketed from 2023. [Read more]

Pfizer et BioNtech préparent des vaccins en poudre pour palier la contrainte du froidPfizer et BioNtech préparent des vaccins en poudre pour palier la contrainte du froidPfizer et BioNtech préparent des vaccins en poudre pour palier la contrainte du froidPfizer et BioNtech préparent des vaccins en poudre pour palier la contrainte du froid Pfizer and BioNTech are making powdered vaccines to get round the refrigeration constraint
A few days ago already Pfizer and BioNTech announced their vaccines against coronavirus were over 95% effective! The only flaw is that these two products are to be stored at minus 80 degrees Celsius (-112°F), leading to logistical issues. Both laboratories are working on a powdered version to get round the problem. [Read more]

Another study: pill vaccine. A product as effective as an injection – as reported by our peers from the Jerusalem Post, explaining the Oravax Medical start-up recently launched their first clinical trial on the matter. A common technique for many medications but which effectiveness is not known as a vaccine.

Covid : Pfizer dévoile son premier traitement oral contre le virusCovid : Pfizer dévoile son premier traitement oral contre le virusCovid : Pfizer dévoile son premier traitement oral contre le virusCovid : Pfizer dévoile son premier traitement oral contre le virus Pfizer: first Covid oral therapy now completing phase 2 of clinical trial
A pill-shaped Covid therapy soon to be available? This Tuesday September 28, 2021, Pfizer laboratory announced they have started phases 2 and 3 of their clinical trial for a medicine of this kind in two locations of the group, and potentially marketed by the end of the year if results are conclusive, after approval from the health authorities. [Read more]

Practical information

Comments
Refine your search
Refine your search
Refine your search
Refine your search